Literature DB >> 31311859

Heat shock protein 90 regulates soluble guanylyl cyclase maturation by a dual mechanism.

Yue Dai1, Simon Schlanger1, Mohammad Mahfuzul Haque1, Saurav Misra2, Dennis J Stuehr3.   

Abstract

The enzyme soluble guanylyl cyclase (sGC) is a heterodimer composed of an α subunit and a heme-containing β subunit. It participates in signaling by generating cGMP in response to nitric oxide (NO). Heme insertion into the β1 subunit of sGC (sGCβ) is critical for function, and heat shock protein 90 (HSP90) associates with heme-free sGCβ (apo-sGCβ) to drive its heme insertion. Here, we tested the accuracy and relevance of a modeled apo-sGCβ-HSP90 complex by constructing sGCβ variants predicted to have an impaired interaction with HSP90. Using site-directed mutagenesis, purified recombinant proteins, mammalian cell expression, and fluorescence approaches, we found that (i) three regions in apo-sGCβ predicted by the model mediate direct complex formation with HSP90 both in vitro and in mammalian cells; (ii) such HSP90 complex formation directly correlates with the extent of heme insertion into apo-sGCβ and with cyclase activity; and (iii) apo-sGCβ mutants possessing an HSP90-binding defect instead bind to sGCα in cells and form inactive, heme-free sGC heterodimers. Our findings uncover the molecular features of the cellular apo-sGCβ-HSP90 complex and reveal its dual importance in enabling heme insertion while preventing inactive heterodimer formation during sGC maturation.
© 2019 Dai et al.

Entities:  

Keywords:  cell signaling; chaperone; client protein; heat shock protein 90 (HSP90); heme; protein folding; protein-protein interaction; structural model

Mesh:

Substances:

Year:  2019        PMID: 31311859      PMCID: PMC6721946          DOI: 10.1074/jbc.RA119.009016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

2.  Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.

Authors:  Peter M Schmidt; Matthias Schramm; Henning Schröder; Frank Wunder; Johannes-Peter Stasch
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

3.  Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases.

Authors:  Patricia Pellicena; David S Karow; Elizabeth M Boon; Michael A Marletta; John Kuriyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.

Authors:  J Lewis; A Devin; A Miller; Y Lin; Y Rodriguez; L Neckers; Z G Liu
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

6.  Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction.

Authors:  E Minet; D Mottet; G Michel; I Roland; M Raes; J Remacle; C Michiels
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

Review 7.  Guanylate cyclase and the .NO/cGMP signaling pathway.

Authors:  J W Denninger; M A Marletta
Journal:  Biochim Biophys Acta       Date:  1999-05-05

8.  Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding.

Authors:  Andreas Papapetropoulos; Zongmin Zhou; Christina Gerassimou; Gunay Yetik; Richard C Venema; Charis Roussos; William C Sessa; John D Catravas
Journal:  Mol Pharmacol       Date:  2005-07-15       Impact factor: 4.436

9.  Hsp90 regulates the activity of wild type p53 under physiological and elevated temperatures.

Authors:  Lin Müller; Andreas Schaupp; Dawid Walerych; Harald Wegele; Johannes Buchner
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

10.  A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.

Authors:  Emil Martin; Iraida Sharina; Alexander Kots; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

View more
  5 in total

1.  GAPDH delivers heme to soluble guanylyl cyclase.

Authors:  Yue Dai; Elizabeth A Sweeny; Simon Schlanger; Arnab Ghosh; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

Review 2.  Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.

Authors:  Zhengnan Yuan; Ladie Kimberly De La Cruz; Xiaoxiao Yang; Binghe Wang
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

3.  Inactivation of soluble guanylyl cyclase in living cells proceeds without loss of haem and involves heterodimer dissociation as a common step.

Authors:  Yue Dai; Dennis J Stuehr
Journal:  Br J Pharmacol       Date:  2021-06-16       Impact factor: 9.473

Review 4.  Maturation, inactivation, and recovery mechanisms of soluble guanylyl cyclase.

Authors:  Dennis J Stuehr; Saurav Misra; Yue Dai; Arnab Ghosh
Journal:  J Biol Chem       Date:  2021-01-26       Impact factor: 5.157

5.  NO rapidly mobilizes cellular heme to trigger assembly of its own receptor.

Authors:  Yue Dai; Emily M Faul; Arnab Ghosh; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 12.779

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.